2332-0121 Screening compound: N-{3,3'-dimethyl-4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}-4-(morpholine-4-sulfonyl)benzamide

2332-0121 Screening compound: N-{3,3'-dimethyl-4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}-4-(morpholine-4-sulfonyl)benzamide
2332-0121 Screening compound: N-{3,3'-dimethyl-4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}-4-(morpholine-4-sulfonyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2332-0121
N-{3,3'-dimethyl-4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}-4-(morpholine-4-sulfonyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2332-0121

Molecular Formula

C36H38N4O8S2 (C36 H38 N4 O8 S2)

Compound Name

N-{3,3'-dimethyl-4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}-4-(morpholine-4-sulfonyl)benzamide

IUPAC name

N-{33'-dimethyl-4'-[4-(morpholine-4-sulfonyl)benzamido]-[11'-biphenyl]-4-yl}-4-(morpholine-4-sulfonyl)benzamide

SMILES

Cc(cc(cc1)-c(cc2)cc(C)c2NC(c(cc2)ccc2S(N2CCOCC2)(=O)=O)=O)c1NC(c(cc1)ccc1S(N1CCOCC1)(=O)=O)=O

InChI

InChI=1S/C36H38N4O8S2/c1-25-23-29(7-13-33(25)37-35(41)27-3-9-31(10-4-27)49(43,44)39-15-19-47-20-16-39)30-8-14-34(26(2)24-30)38-36(42)28-5-11-32(12-6-28)50(45,46)40-17-21-48-22-18-40/h3-14,23-24H,15-22H2,1-2H3,(H,37,41)(H,38,42)

InChI Key

ICQGISQYMWKVSY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00990538

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

718.85

Hydrogen Bond Acceptors Count

16.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

12

Partition Coefficient, logP

4.169

Distribution Coefficient, logD

4.168

Water Solubility, LogSw

-4.10

Polar Surface Area

123.993

Acid Dissociation Constant (pKa)

10.66

Base Dissociation Constant (pKb)

-2.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.80

2332-0121 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 2332-0121 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2332-0121?
Check Price and Availability of 2332-0121, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2332-0121 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2332-0121
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2332-0121
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2332-0121 available by request